Literature DB >> 24728183

RUVBL1 directly binds actin filaments and induces formation of cell protrusions to promote pancreatic cancer cell invasion.

Keisuke Taniuchi1, Mutsuo Furihata2, Shinji Iwasaki3, Kenjiro Tanaka1, Takahiro Shimizu1, Motoaki Saito1, Toshiji Saibara3.   

Abstract

We report a novel function of RUVBL1 molecule in pancreatic cancer cells. Previous reports describe that RUVBL1 belongs to the family of AAA+ ATPases that associate with chromatin-remodelling complexes and have important roles in transcriptional regulation, the DNA damage response, telomerase activity and cellular transformation. We show that knockdown of RUVBL1 inhibited the motility and invasiveness of pancreatic cancer cells. RUVBL1 localized in the cytoplasm bound filamentous actin (F-actin) in cell protrusions, and increased concentration of monomeric globular-actin (G-actin) in cell protrusions of migrating pancreatic cancer cells. Cytoplasmic RUVBL1 functioned in additional formation of actin filaments in cell protrusions. Consequently, cytoplasmic RUVBL1 contributed to the formation of membrane protrusions by promoting peripheral actin polymerization. Our results imply that these RUVBL1-actin interactions could enhance the invasive properties of pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24728183     DOI: 10.3892/ijo.2014.2380

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.

Authors:  Charles Chuanhai Guo; Vipulkumar Dadhania; Li Zhang; Tadeusz Majewski; Jolanta Bondaruk; Maciej Sykulski; Weronika Wronowska; Anna Gambin; Yan Wang; Shizhen Zhang; Enrique Fuentes-Mattei; Ashish Madhav Kamat; Colin Dinney; Arlene Siefker-Radtke; Woonyoung Choi; Keith A Baggerly; David McConkey; John N Weinstein; Bogdan Czerniak
Journal:  Eur Urol       Date:  2016-03-15       Impact factor: 20.096

2.  F-actin organizes the nucleus.

Authors:  Henna M Moore; Maria K Vartiainen
Journal:  Nat Cell Biol       Date:  2017-11-29       Impact factor: 28.824

3.  RUVBL1 promotes enzalutamide resistance of prostate tumors through the PLXNA1-CRAF-MAPK pathway.

Authors:  Feifei Sun; Xinpei Wang; Jing Hu; Junmei Liu; Xin Wang; Wenqiao Jia; Zeyuan Yu; Lin Gao; Baokai Dou; Ru Zhao; Tingting Feng; Xueli Wang; Wenbo Zhang; Hui Liu; Kaihua Liu; Yang Shao; Xuesen Dong; Bo Han
Journal:  Oncogene       Date:  2022-05-04       Impact factor: 9.867

4.  High copy number variations, particular transcription factors, and low immunity contribute to the stemness of prostate cancer cells.

Authors:  Zao Dai; Ping Liu
Journal:  J Transl Med       Date:  2021-05-13       Impact factor: 5.531

5.  ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.

Authors:  Anbin Wang; Haisu Dai; Yi Gong; Chengcheng Zhang; Junjie Shu; Yuandeng Luo; Yan Jiang; Wei Liu; Ping Bie
Journal:  J Exp Clin Cancer Res       Date:  2019-08-08

Review 6.  The Emerging Roles of ATP-Dependent Chromatin Remodeling Complexes in Pancreatic Cancer.

Authors:  Nesrin Hasan; Nita Ahuja
Journal:  Cancers (Basel)       Date:  2019-11-25       Impact factor: 6.639

7.  Identification of Key Deregulated RNA-Binding Proteins in Pancreatic Cancer by Meta-Analysis and Prediction of Their Role as Modulators of Oncogenesis.

Authors:  Moumita Mukherjee; Srikanta Goswami
Journal:  Front Cell Dev Biol       Date:  2021-11-29

8.  High expression of RUVBL1 and HNRNPU is associated with poor overall survival in stage I and II non-small cell lung cancer patients.

Authors:  Justyna Durślewicz; Jakub Jóźwicki; Anna Klimaszewska-Wiśniewska; Aleksandra Zielińska; Paulina Antosik; Dariusz Grzanka; Marcin Braun
Journal:  Discov Oncol       Date:  2022-10-15

Review 9.  The Role of Pontin and Reptin in Cellular Physiology and Cancer Etiology.

Authors:  Yu-Qian Mao; Walid A Houry
Journal:  Front Mol Biosci       Date:  2017-08-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.